• Profile
Close

Identification of prognostic biomarkers in the urinary peptidome of the small renal mass

American Journal of Pathology Dec 06, 2019

Di Meo A, Batruch I, Brown MD, et al. - Using a quantitative label-free liquid chromatography-tandem mass spectrometry peptidomics strategy and targeted parallel-reaction monitoring, 115 urine samples, comprising of 33 renal oncocytomas (≤ 4 cm) cases, 30 progressive and 26 nonprogressive clear cell renal cell carcinoma (RCC)-small renal mass (SRM) cases, and 26 healthy controls were assessed in order to distinguish early, noninvasive diagnostic and prognostic biomarkers for early-stage RCC-SRMs. Results imply that pretreatment characterization of urinary peptides could give perspicacity into early RCC progression and may help in clinical decision-making and enhance disease management.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay